Table: Fuji Pharma -2025/26 parent results

Fuji Pharma

10/11/2026 07:30

Nov 10 (Reuters)-
Fuji Pharma
PARENT-ONLY FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

             Year ended    Year ended     Year to
           Sep 30, 2026  Sep 30, 2025  Sep 30, 2027
              LATEST       YEAR-AGO      COMPANY
             RESULTS       RESULTS       FORECAST
Sales         57.18         47.49           --
           (+20.4 pct)   (+13.3 pct)
Operating      5.37          4.21           --
           (+27.8 pct)   (+22.6 pct)
Recurring      5.21          3.70           --
           (+40.8 pct)    (-6.4 pct)
Net            2.06          2.45           --
           (-15.8 pct)   (-57.8 pct)
EPS         81.05 yen     100.50 yen        --
Ann Div     52.00 yen     45.50 yen     58.50 yen
-Q2 div     23.00 yen     20.00 yen     28.00 yen
-Q4 div     29.00 yen     25.50 yen     30.50 yen


NOTE - Fuji Pharma.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T